Aadi Bioscience Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Aadi Bioscience Stock Summary

Aadi Bioscience competes with Anebulo Pharmaceuticals, Adagene, Acrivon Therapeutics,, AnaptysBio, and Mineralys Therapeutics,. Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.

Aadi Bioscience Key Financial Ratios

Aadi Bioscience Key Balance Sheet Accounts

Aadi Bioscience Key Income Statement Accounts

Aadi Bioscience Key Cash Accounts

Aadi Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aadi Bioscience's current stock value. Our valuation model uses many indicators to compare Aadi Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aadi Bioscience competition to find correlations between indicators driving Aadi Bioscience's intrinsic value. More Info.Aadi Bioscience is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Aadi Bioscience's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aadi Bioscience's earnings, one of the primary drivers of an investment's value.

Aadi Bioscience Systematic Risk

Today, most investors in Aadi Bioscience Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aadi Bioscience's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aadi Bioscience growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Aadi Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aadi Bioscience. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aadi Bioscience based on widely used predictive technical indicators. In general, we focus on analyzing Aadi Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aadi Bioscience's daily price indicators and compare them against related drivers.

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.